{"title":"新型精神分裂症药物可治疗阿尔茨海默病","authors":"Diana Kwon","doi":"10.1038/d41586-024-03707-5","DOIUrl":null,"url":null,"abstract":"Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.","PeriodicalId":18787,"journal":{"name":"Nature","volume":"635 8040","pages":"796-797"},"PeriodicalIF":56.1000,"publicationDate":"2024-11-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.nature.com/articles/d41586-024-03707-5.pdf","citationCount":"0","resultStr":"{\"title\":\"New schizophrenia drug could treat Alzheimer’s disease\",\"authors\":\"Diana Kwon\",\"doi\":\"10.1038/d41586-024-03707-5\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.\",\"PeriodicalId\":18787,\"journal\":{\"name\":\"Nature\",\"volume\":\"635 8040\",\"pages\":\"796-797\"},\"PeriodicalIF\":56.1000,\"publicationDate\":\"2024-11-21\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.nature.com/articles/d41586-024-03707-5.pdf\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Nature\",\"FirstCategoryId\":\"103\",\"ListUrlMain\":\"https://www.nature.com/articles/d41586-024-03707-5\",\"RegionNum\":1,\"RegionCategory\":\"综合性期刊\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"MULTIDISCIPLINARY SCIENCES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Nature","FirstCategoryId":"103","ListUrlMain":"https://www.nature.com/articles/d41586-024-03707-5","RegionNum":1,"RegionCategory":"综合性期刊","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MULTIDISCIPLINARY SCIENCES","Score":null,"Total":0}
New schizophrenia drug could treat Alzheimer’s disease
Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed. Half a dozen drugs are in trials for conditions of the brain, but success is not guaranteed.
期刊介绍：
Nature is a prestigious international journal that publishes peer-reviewed research in various scientific and technological fields. The selection of articles is based on criteria such as originality, importance, interdisciplinary relevance, timeliness, accessibility, elegance, and surprising conclusions. In addition to showcasing significant scientific advances, Nature delivers rapid, authoritative, insightful news, and interpretation of current and upcoming trends impacting science, scientists, and the broader public. The journal serves a dual purpose: firstly, to promptly share noteworthy scientific advances and foster discussions among scientists, and secondly, to ensure the swift dissemination of scientific results globally, emphasizing their significance for knowledge, culture, and daily life.
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
